Mounjaro Mounjaro contains tirzepatide, a dual GIP and GLP-1 agonist
A 2017 meta-analysis published in the Journal of Strength and Conditioning Research found that creatine supplementation combined with resistance training produced significantly greater gains in lean mass and strength compared to resistance training alone across multiple populations and age groups
Offering patients the benefits of a GLP-1 receptor agonist in a once-daily tablet could overcome some of the obstacles that lead to therapeutic inertia, as evidence suggests that patient concerns over potential side effects of therapies, including hypoglycaemia and weight gain, as well as fear of injections, often lead to delayed intensification of treatment, despite poor glycaemic control [12, 46,47,48]
Lastly, the platform's clean technology philosophy ensures that data is presented clearly and accessibly
Our Approach to Sustainable Weight Management At the core of our sustainable weight management program lies an extensive, personalized approach that combines innovative medical treatments with lifestyle optimization
